Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
Conditions
Acute Adult T-Cell Leukemia/Lymphoma · Adult T-Cell Leukemia/Lymphoma · Chronic Adult T-Cell Leukemia/Lymphoma · HTLV-1 Infection
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Emory University Hospital Midtown, Atlanta, Georgia, United States
Contact: Principal Investigator (Pamela B. Allen)Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Principal Investigator (Pamela B. Allen)Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States
Contact: Principal Investigator (Lee Ratner)Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States
Contact: Principal Investigator (Lee Ratner)Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Lee Ratner)Siteman Cancer Center-South County, St Louis, Missouri, United States
Contact: Principal Investigator (Lee Ratner)Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
Contact: Principal Investigator (Steven M. Horwitz)Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Contact: Principal Investigator (Steven M. Horwitz)Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Contact: Principal Investigator (Steven M. Horwitz)Memorial Sloan Kettering Commack, Commack, New York, United States
Contact: Principal Investigator (Steven M. Horwitz)Memorial Sloan Kettering Westchester, Harrison, New York, United States
Contact: Principal Investigator (Steven M. Horwitz)NYU Langone Hospital - Long Island, Mineola, New York, United States
Contact: Principal Investigator (Catherine S. Diefenbach)Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States
Contact: Principal Investigator (Catherine S. Diefenbach)NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@cumc.columbia.edu · 212-342-5162Contact: Principal Investigator (Jennifer E. Amengual)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Steven M. Horwitz)NYP/Weill Cornell Medical Center, New York, New York, United States
Contact: Principal Investigator (Jia Ruan)Memorial Sloan Kettering Nassau, Uniondale, New York, United States
Contact: Principal Investigator (Steven M. Horwitz)Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Principal Investigator (Jonathan E. Brammer)VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States
Contact: Principal Investigator (Bruce O. Hough)
Study leads
Lee Ratner
Principal Investigator
Yale University Cancer Center LAO